Johns Hopkins Center of Excellence in Regulatory Science and Innovation (JH-CERSI) and U.S. Food and Drug Administration (FDA)
Nov. 28, 2018
FDA WHITE OAK CAMPUS, BLDG. 31
10903 New Hampshire Avenue
Silver Spring, MD 20993
This symposium is comprised of talks and panel discussions by leading experts that engages various stakeholders in how to assess and communicate heterogeneity of treatment effects (HTE).
The symposium will focus on the following topics:
Posted: Aug. 13, 2018